JenaValve announced today that it began patient enrollment in the ARTIST study evaluating its Trilogy heart valve system.

WASHINGTON — Among patients with asymptomatic severe aortic stenosis and myocardial fibrosis, transcatheter or surgical aortic valve replacement did not improve outcomes compared with guideline ...

Transcatheter aortic valve implantation (TAVI) is now an established treatment option for elderly patients with severe ...

The study isn’t intended to sway clinical decision-making, but to make doctors aware of the impact of their choices.

JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced that patient enrollment has begun in the ARTIST study, an RCT evaluating ...

Caranx Medical ("Caranx"), a French medical device company specializing in the development of an autonomous robot to democratize access to Transcatheter Aortic Valve Implantation (TAVI), a lifesaving ...

For the first time in India, doctors at Rajasthan Hospital, Jaipur have successfully replaced a heart valve through the ...

MiRus announced new early feasibility study results supporting the use of its Siegel transcatheter aortic valve replacement ...

monitoring and aortic valve replacement only when symptoms developed, or aortic valve replacement. For patients with asymptomatic, severe AS, ...

Overview of Prosthetic Heart Valve MarketThe Global Prosthetic Heart Valve Market is valued at USD 8.74 Billion in 2024 and ...

Find out what you need to know about your aortic valve — where it's located, what it does, and how it works. Learn about the symptoms, causes, and treatments for aortic valve conditions.